advertisement
11.4 Prostaglandins (20)
Showing records 1 to 20
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins55430 Effects of several anti-glaucoma medications on the circadian intraocular pressure fluctuations in patients with primary open-angle glaucoma
Tanaka S; Watanabe M; Inatomi S; Umeda K; Yoshida K; Ohguro I; Ohguro H
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 12-20
55263 Long-term efficacy of latanoprost in primary congenital glaucoma
Uva MG; Avitabile T; Reibaldi M; Bucolo C; Drago F; Quaranta L; Lionetti E; Longo A
Eye 2014; 28: 53-57
55656 Travoprost with sofZia® preservative system lowered intraocular pressure of Japanese normal tension glaucoma with minimal side effects
Mizoue S; Nakano T; Fuse N; Iwase A; Matsumoto S; Yoshikawa K
Clinical Ophthalmology 2014; 8: 347-354
55776 Meta-analysis of randomized controlled trials comparing latanoprost with timolol in the treatment of asian populations with chronic angle-closure glaucoma
Li SM; Chen R; Li Y; Yang ZR; Deng QJ; Zhong Z; Ong ML; Zhan SY
PLoS ONE 2014; 9: e96852
55648 Periorbital muscle atrophy associated with topical bimatoprost therapy
Wang PX; Koh VT; Cheng JF
Clinical Ophthalmology 2014; 8: 311-314
55544 Effects of prostaglandin analogues on aqueous humor outflow pathways
Winkler NS; Fautsch MP
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 102-109
55715 An evidence-based review of unoprostone isopropyl ophthalmic solution 0.15% for glaucoma: place in therapy
Fung DS; Whitson JT
Clinical Ophthalmology 2014; 8: 543-554
55673 Ocular Surface Cytotoxicity and Safety Evaluation of Tafluprost, a Recently Developed Anti-Glaucoma Prostaglandin Analog
Niwano Y; Iwasawa A; Ayaki M
Ophthalmology and eye diseases 2014; 6: 5-12
55189 The effect of prostaglandin analogs on the biomechanical properties and central thickness of the cornea of patients with open-angle glaucoma: a 3-year study on 108 eyes
Tsikripis P; Papaconstantinou D; Koutsandrea C; Apostolopoulos M; Georgalas I
Drug design, development and therapy 2013; 7: 1149-1156
55099 Effects of prostaglandin F(2α) on adipocyte biology relevant to graves' orbitopathy
Draman MS; Grennan-Jones F; Zhang L; Taylor PN; Tun TK; McDermott J; Moriarty P; Morris D; Lane C; Sreenan S; Dayan C; Ludgate M
Thyroid 2013; 23: 1600-1608
55201 The United Kingdom Glaucoma Treatment Study: a multicenter, randomized, double-masked, placebo-controlled trial: baseline characteristics
Lascaratos G; Garway-Heath DF; Burton R; Bunce C; Xing W; Crabb DP; Russell RA; Shah A;
Ophthalmology 2013; 120: 2540-2545
55290 The diurnal and nocturnal effect of travoprost with sofZia on intraocular pressure and ocular perfusion pressure
Seibold LK; Kahook MY
American Journal of Ophthalmology 2014; 157: 44-49.e1
55671 Research progress of the side effect of the prostaglandin drugs
Liu XY; Tang L; Peng YH; Chen XM; Wang NL
Chinese Journal of Ophthalmology 2013; 49: 1045-1048
55736 Bimatoprost 0.01% or 0.03% in patients with glaucoma or ocular hypertension previously treated with latanoprost: two randomized 12-week trials
Myers JS; Vold S; Zaman F; Williams JM; Hollander DA
Clinical Ophthalmology 2014; 8: 643-652
55764 A 4-year retrospective study of add-on therapy to the fixed combination of dorzolamide/timolol for the treatment of POAG
Hartleben-Matkin C; Prada D; Mancilla-Vences R
International Journal of Ophthalmology 2014; 7: 330-334
55753 Bimatoprost/timolol fixed combination versus latanoprost in treatment-naïve glaucoma patients at high risk of progression: a pilot study
Gutierrez-Diaz E; Silva Cotta J; Muñoz-Negrete FJ; Gutierrez-Ortiz C; Morgan-Warren RJ; Maltman J
Clinical Ophthalmology 2014; 8: 725-732
55749 Comparison of latanoprost/timolol with carbonic anhydrase inhibitor and dorzolamide/timolol with prostaglandin analog in the treatment of glaucoma
Inoue K; Soeda S; Tomita G
Journal of Ophthalmology 2014; 2014: 975429
55757 Bimatoprost-loaded ocular inserts as sustained release drug delivery systems for glaucoma treatment: in vitro and in vivo evaluation
Franca JR; Foureaux G; Fuscaldi LL; Ribeiro TG; Rodrigues LB; Bravo R; Castilho RO; Yoshida MI; Cardoso VN; Fernandes SO; Cronemberger S; Ferreira AJ; Faraco AA
PLoS ONE 2014; 9: e95461
55672 Changes in the morphological and functional patterns of the ocular surface in patients treated with prostaglandin analogues after the use of TSP 0.5%® preservative-free eyedrops: a prospective, multicenter study
Iester M; Oddone F; Fogagnolo P; Frezzotti P; Figus M;
Ophthalmic Research 2014; 51: 146-152
55467 In vitro effects of preservative-free and preserved prostaglandin analogs on primary cultured human conjunctival fibroblast cells
Kim EJ; Kim YH; Kang SH; Lee KW; Park YJ
Korean Journal of Ophthalmology 2013; 27: 446-453
